three patients with acute myelogenous leukemia ( aml ) in relapse were treated with intravenous infusions of one or more purified murine monoclonal antibodies ( moabs ) specific for differentiation antigens on normal and malignant myeloid cells .
C0023467
acute myelogenous leukemia
C0334227
malignant